Literature DB >> 23592598

Accuracy of Canadian health administrative databases in identifying patients with rheumatoid arthritis: a validation study using the medical records of rheumatologists.

Jessica Widdifield1, Sasha Bernatsky, J Michael Paterson, Karen Tu, Ryan Ng, J Carter Thorne, Janet E Pope, Claire Bombardier.   

Abstract

OBJECTIVE: Health administrative data can be a valuable tool for disease surveillance and research. Few studies have rigorously evaluated the accuracy of administrative databases for identifying rheumatoid arthritis (RA) patients. Our aim was to validate administrative data algorithms to identify RA patients in Ontario, Canada.
METHODS: We performed a retrospective review of a random sample of 450 patients from 18 rheumatology clinics. Using rheumatologist-reported diagnosis as the reference standard, we tested and validated different combinations of physician billing, hospitalization, and pharmacy data.
RESULTS: One hundred forty-nine rheumatology patients were classified as having RA and 301 were classified as not having RA based on our reference standard definition (study RA prevalence 33%). Overall, algorithms that included physician billings had excellent sensitivity (range 94-100%). Specificity and positive predictive value (PPV) were modest to excellent and increased when algorithms included multiple physician claims or specialist claims. The addition of RA medications did not significantly improve algorithm performance. The algorithm of "(1 hospitalization RA code ever) OR (3 physician RA diagnosis codes [claims] with ≥1 by a specialist in a 2-year period)" had a sensitivity of 97%, specificity of 85%, PPV of 76%, and negative predictive value of 98%. Most RA patients (84%) had an RA diagnosis code present in the administrative data within ±1 year of a rheumatologist's documented diagnosis date.
CONCLUSION: We demonstrated that administrative data can be used to identify RA patients with a high degree of accuracy. RA diagnosis date and disease duration are fairly well estimated from administrative data in jurisdictions of universal health care insurance.
Copyright © 2013 by the American College of Rheumatology.

Entities:  

Mesh:

Year:  2013        PMID: 23592598     DOI: 10.1002/acr.22031

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  47 in total

1.  Validation of administrative case ascertainment algorithms for chronic childhood arthritis in Manitoba, Canada.

Authors:  Natalie Jane Shiff; Kiem Oen; Rasheda Rabbani; Lisa M Lix
Journal:  Rheumatol Int       Date:  2017-05-13       Impact factor: 2.631

2.  Increasing comorbidity and health services utilization in older adults with prior stroke.

Authors:  Andrea Gruneir; Lauren E Griffith; Kathryn Fisher; Dilzayn Panjwani; Sima Gandhi; Li Sheng; Chris Patterson; Amiram Gafni; Jenny Ploeg; Maureen Markle-Reid
Journal:  Neurology       Date:  2016-10-19       Impact factor: 9.910

3.  Influence of opioid prescribing standards on health outcomes among patients with long-term opioid use: a longitudinal cohort study.

Authors:  Richard L Morrow; Ken Bassett; James M Wright; Greg Carney; Colin R Dormuth
Journal:  CMAJ Open       Date:  2020-12-18

Review 4.  Progress in Biomedical Knowledge Discovery: A 25-year Retrospective.

Authors:  L Sacchi; J H Holmes
Journal:  Yearb Med Inform       Date:  2016-08-02

5.  Characteristics of health care related to mental health and substance use disorders among Community Health Centre clients in Ontario: a population-based cohort study.

Authors:  Richard G Booth; Lucie Richard; Lihua Li; Salimah Z Shariff; Jennifer Rayner
Journal:  CMAJ Open       Date:  2020-05-23

6.  Temporal trends in prevalence, incidence, and mortality for rheumatoid arthritis in Quebec, Canada: a population-based study.

Authors:  Sonia Jean; Marie Hudson; Philippe Gamache; Louis Bessette; Paul R Fortin; Gilles Boire; Sasha Bernatsky
Journal:  Clin Rheumatol       Date:  2017-08-21       Impact factor: 2.980

7.  Rheumatoid arthritis pharmacotherapy and predictors of disease-modifying anti-rheumatic drug initiation in the early years of biologic use in Quebec, Canada.

Authors:  Jean-Pascal Roussy; Louis Bessette; Elham Rahme; Sasha Bernatsky; Jean Légaré; Jean Lachaine
Journal:  Rheumatol Int       Date:  2013-08-20       Impact factor: 2.631

8.  Population Variations in Rheumatoid Arthritis Treatment and Outcomes, Northern California, 1998-2009.

Authors:  Lisa J Herrinton; Leslie Harrold; Craig Salman; Liyan Liu; Robert Goldfien; Maryam Asgari; Joel M Gelfand; Jashin J Wu; Jeffrey R Curtis
Journal:  Perm J       Date:  2015-12-21

9.  Comparative risk of harm associated with trazodone or atypical antipsychotic use in older adults with dementia: a retrospective cohort study.

Authors:  Jennifer A Watt; Tara Gomes; Susan E Bronskill; Anjie Huang; Peter C Austin; Joanne M Ho; Sharon E Straus
Journal:  CMAJ       Date:  2018-11-26       Impact factor: 8.262

10.  Validity of juvenile idiopathic arthritis diagnoses using administrative health data.

Authors:  Elizabeth Stringer; Sasha Bernatsky
Journal:  Rheumatol Int       Date:  2014-10-01       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.